399 related articles for article (PubMed ID: 17552031)
1. Hepatitis C virus-related lymphoproliferative disorders: an overview.
Zignego AL; Giannini C; Ferri C
World J Gastroenterol; 2007 May; 13(17):2467-78. PubMed ID: 17552031
[TBL] [Abstract][Full Text] [Related]
2. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach.
Zignego AL; Ferri C; Pileri SA; Caini P; Bianchi FB;
Dig Liver Dis; 2007 Jan; 39(1):2-17. PubMed ID: 16884964
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Extrahepatic Manifestations of Hepatitis C Virus.
Degasperi E; Aghemo A; Colombo M
Clin Liver Dis; 2017 Aug; 21(3):631-643. PubMed ID: 28689598
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
5. HCV infection: pathogenesis, clinical manifestations and therapy.
Antonelli A; Ferri C; Galeazzi M; Giannitti C; Manno D; Mieli-Vergani G; Menegatti E; Olivieri I; Puoti M; Palazzi C; Roccatello D; Vergani D; Sarzi-Puttini P; Atzeni F
Clin Exp Rheumatol; 2008; 26(1 Suppl 48):S39-47. PubMed ID: 18570753
[TBL] [Abstract][Full Text] [Related]
6. [Extrahepatic manifestations of HCV infection].
Husa P
Vnitr Lek; 2016; 62(9 Suppl 2):18-22. PubMed ID: 27723989
[TBL] [Abstract][Full Text] [Related]
7. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.
Stefanova-Petrova DV; Tzvetanska AH; Naumova EJ; Mihailova AP; Hadjiev EA; Dikova RP; Vukov MI; Tchernev KG
World J Gastroenterol; 2007 Dec; 13(48):6518-28. PubMed ID: 18161922
[TBL] [Abstract][Full Text] [Related]
8. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
[TBL] [Abstract][Full Text] [Related]
9. HCV-related lymphoproliferative disorders in the direct-acting antiviral era: From mixed cryoglobulinaemia to B-cell lymphoma.
Cacoub P; Comarmond C; Vieira M; Régnier P; Saadoun D
J Hepatol; 2022 Jan; 76(1):174-185. PubMed ID: 34600000
[TBL] [Abstract][Full Text] [Related]
10. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
[TBL] [Abstract][Full Text] [Related]
11. [Skin diseases and hepatitis virus C infection].
Poljacki M; Gajinov Z; Ivkov M; Matić M; Golusin Z
Med Pregl; 2000; 53(3-4):141-5. PubMed ID: 10965678
[TBL] [Abstract][Full Text] [Related]
12. HCV and lymphoproliferative diseases.
Trépo C; Berthillon P; Vitvitski L
Ann Oncol; 1998 May; 9(5):469-70. PubMed ID: 9653484
[No Abstract] [Full Text] [Related]
13. Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.
Pozzato G; Mazzaro C; Gattei V
Minerva Med; 2021 Apr; 112(2):215-227. PubMed ID: 33263375
[TBL] [Abstract][Full Text] [Related]
14. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.
Lamprecht P; Lerin-Lozano C; Merz H; Dennin RH; Gause A; Voswinkel J; Peters SO; Gutzeit O; Arlt AC; Solbach W; Gross WL
Ann Rheum Dis; 2003 Dec; 62(12):1230-3. PubMed ID: 14644867
[TBL] [Abstract][Full Text] [Related]
15. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.
Wiznia LE; Laird ME; Franks AG
J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1260-1270. PubMed ID: 28252812
[TBL] [Abstract][Full Text] [Related]
17. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
Giordano TP; Henderson L; Landgren O; Chiao EY; Kramer JR; El-Serag H; Engels EA
JAMA; 2007 May; 297(18):2010-7. PubMed ID: 17488966
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.
Younossi Z; Park H; Henry L; Adeyemi A; Stepanova M
Gastroenterology; 2016 Jun; 150(7):1599-1608. PubMed ID: 26924097
[TBL] [Abstract][Full Text] [Related]
19. HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems.
Milovanova SY; Lysenko Kozlovskaya LV; Milovanova LY; Mrykhin NN; Russkih AV; Muchin NA
Ter Arkh; 2018 Jun; 90(6):112-120. PubMed ID: 30701914
[TBL] [Abstract][Full Text] [Related]
20. HCV infection and extrahepatic manifestations.
Nocente R; Ceccanti M; Bertazzoni G; Cammarota G; Silveri NG; Gasbarrini G
Hepatogastroenterology; 2003; 50(52):1149-54. PubMed ID: 12846002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]